TD Cowen analysts trimmed the price target for Eli Lilly and Company (NYSE:LLY) from $1,050 to $960, while reiterating a Buy ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is ...

Rosnilimab met key RA trial goals, with sustained clinical responses and safety benefits, prompting an analyst upgrade and price target hike to $38. Vandana Singh Mounjaro Maker Eli Lilly Taps ...

And when you're looking even further ahead, at the next five years, the valuation may be even more justifiable as Eli Lilly stock trades at a price/earnings-to-growth (PEG) multiple of around 0.75.

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.

Going by what you pay per dollar of sales or profit, LLY stock looks very expensive compared to the broader market. Eli Lilly and has a price-to-sales (P/S) ratio of 16.6 vs. a figure of 2.8 for ...

Eli Lilly has been a favorite among pharmaceutical ... while the tech-heavy Nasdaq Composite has rocketed by 72%. With a stock price of almost $900 per share, I think Lilly could make a good ...

Eli Lilly shares dropped more than 4% on ... Week's 50% Surge—Watch These Key Levels Watch These D-Wave Price Levels as Quantum Computing Stock Soars on Next-Gen Launch ...

From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE ... for the next line of drugs front ran the stock price. For example, in 2016 Lilly was trading 13 times the trailing 12 months ...